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Abstract 
 
Introduction 
Sentinel node biopsy (SNB) is gaining popularity as a staging tool in oral cancer. 
Protocol mandates radiotracer injection and pre-operative imaging (LSG +/- 
SPECT/CT) in the nuclear medicine department. This approach limits application 
to accessible tumours and to centres with nuclear medicine. New technology, 
freehand single photon emission computed tomography (fhSPECT), has proved a 
useful adjunct in intraoperative imaging and localisation of sentinel nodes. This 
study investigates fhSPECT as an alternative to traditional imaging, an approach 
that would widen the remit of SNB. 
Methods 
Fifty consecutive cT1-T2 N0 oral cancer patients received radiotracer followed 
by lymphoscintigraphy and SPECT/CT. Surgery was undertaken using fhSPECT 
by a surgeon blinded to pre-operative imaging. Prior to biopsy completion, 
results of pre-operative imaging were reviewed and any additional nodes 
removed. The accuracy of LSG, SPECT/CT and fhSPECT were compared. 
Results 
Nineteen patients had positive sentinel nodes. Disease free survival for sentinel 
node positive versus negative was significant (p<0.005) 
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 All modalities missed positive nodes in at least one patient. The false negative 
rate for lymphoscintigraphy, SPECT/CT and fhSPECT was 26.3%, 15.8% and 
5.3% respectively.  
Discussion 
These data show a surgeon naïve to the results of traditional pre-operative 
sentinel node imaging can use fhSPECT in the operating theatre to accurately 
locate sentinel nodes in oral cancer. Freehand SPECT showed excellent 
sensitivity and a low false negative rate offering the possibility of a streamlined 
intraoperative sentinel node protocol. 
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1 Introduction  
 
The complex nature of lymphatic drainage within the head and neck means that 
intraoperative identification of sentinel nodes (SNs) is always informed by pre-
operative imaging, traditionally lymphoscintigraphy (LSG) and/or Single Photon 
Emission Computed Tomography (SPECT)/CT)[1-4]. These imaging modalities 
are outpatient based, with radiotracer injection up 24 hours prior to surgery[1, 
5]. Results of multiple sentinel node biopsy (SNB) studies have shown promising 
results in early oral cancer with large studies reporting overall sensitivity 88-
97% in detection of occult neck metastasis[2, 3, 6, 7]. Detection rates vary 
depending upon the imaging modality used, with the sensitivity of LSG ranging 
between 81-93%, and SPECT/CT 93-100%[8-11].  These imaging modalities 
have proven utility but disadvantages include requirement for expensive gantry 
based equipment, long imaging times (up to 90 minutes), multiple staff members 
involved, and the tumour must be readily accessible to inject[12]. New more 
flexible technology (e.g. freehand SPECT, hand-held gamma cameras) may be 
used to allow intraoperative SN imaging thus reducing the cost of the pathway as 
well as opening the technique to deeper tumours that are only accessible with 
the patient under general anaesthetic[13-15]. 
A recently described method of imaging by freehand SPECT (fhSPECT) allows 
real-time intraoperative lymphoscintographic mapping for SNB combining a 
hand-held detector (traditional gamma probe) with a patient-tracking device[16-
18]. Gamma counts recorded by hand-held probe ‘scanning’ the patient from 
different angles are processed by iterative algorithms to produce a three-
dimensional (3-D) map of radiation hot spots. These data are combined with 
contemporaneous video recording, producing an augmented reality  (AR) 
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composite image of the patient and superimposed radiation signal. The user can 
switch between AR and 3-D navigation mode to localise sentinel nodes during 
surgery. The advantage of fhSPECT is the ability to build up a dynamic mapping 
within the region of interest, not limited to a specific field of view, that can move 
with changes in the patient’s position during surgery. It also allows for re-
scanning during the procedure to reflect changes in anatomy.  
Review of the literature reveal a small number of case reports and pilot studies 
using fhSPECT for SNB detection in breast cancer[16, 18-21], melanoma[22, 23] 
prostate cancer[24, 25]  oropharyngeal tumours [26] and oral cancer[27, 28]. 
Two publications present case series in oral cancer. Bluemel et al.[29]published 
a series of twenty-three oral cancer patients in whom pre-operative scanning by 
fhSPECT had a 98% detection rate (out performing lymphoscintigraphy but not 
SPECT/CT) however, the investigators were not blinded to the results of the 
conventional nuclear medicine imaging prior to scanning with fhSPECT [30]. 
Additionally all patients had concurrent neck dissection, potentially masking any 
failings in the technique. Heuvleing et al.[31] published a case series of 66 
patients with cT1-T2 N0 oral cancer who underwent SNB using fhSPECT. In this 
study fhSPECT identified 94% of the sentinel nodes that had been identified pre-
operatively, however it should be noted that the position of the nodes had been 
marked on the neck by the nuclear medicine team prior to the surgeon scanning 
with the fhSPECT system. Investigators asked the surgeons to rate on a three-
point scale the usefulness of the system in identifying and retrieving the nodes 
during surgery, and found that it provided additional useful information in 24% 
of cases 
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To date fhSPECT has only been investigated as an adjunct to traditional sentinel 
node imaging rather than an independent localisation modality for SNB. 
However, if fhSPECT proves accurate enough to localise sentinel nodes without 
the need for gantry-based outpatient imaging, the whole procedure could be 
undertaken in the operating theatre thus reducing the time and cost incurred.  
If successful, this would open the application of SNB to tumours that are only 
accessible for injection with radiotracer once the patient is under general 
anaesthetic.  
 
This study aims to assess whether fhSPECT guided sentinel node biopsy can be 
accurately undertaken in patients with oral cancer by a surgeon who has been 
blinded to the results of pre-operative LSG and SPECT/CT. The accuracy of three 
imaging modalities  (fhSPECT, lymphoscintigraphy (LSG) and SPECT/CT) are 
measured by sentinel node identification rate, identification of positive sentinel 
nodes, and false negative rate. A secondary aim is to understand the optimum 
post injection window for identification of lymphatic drainage by fhSPECT, thus 
informing any future protocol that may rely on the intraoperative delivery of 
radiotracers.  
2. Materials and methods 
 
Ethical permission was granted to recruit patients with cT1-T2 N0 oral 
squamous cell carcinoma (SCC) who were suitable for sentinel node biopsy.  
Patients have given general consent for images to be used in teaching including 
publications. 
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2.1 Outpatient nuclear medicine imaging 
 
Patients underwent peritumoural injection of radiotracer (99mTc-Nanocoll) up 
to 24 hours prior to surgery. The total effective dose was 40-80Mbq for a two 
day and 10-20 MBq for a one-day protocol.  
Immediate planar imaging was performed using a dual head gamma camera 
(e.cam, Siemens Healthcare, Munich Germany) using a low energy high-
resolution collimator with 9.1mm resolution[32]. Dynamic images were taken in 
the anterior or oblique view (20 x 60s, 128 x128 matrix). Directly after dynamic 
imaging static images (120s or 300s, 256 x 256 matrix) were acquired. Patients 
then underwent SPECT/CT imaging using a dual-detector gamma camera with a 
mounted 2-row multidetector CT scanner with intrinsic resolution of 3.8mm[33] 
(Symbia T, Siemens Healthcare). SPECT protocol used 128×128 matrix by180° in 
the anterior L-mode rotation with 3° angle step and 20–25 seconds per 
projection, in 8 iterations, using correction for attenuation and scatter.  CT 
images were obtained by 130kV 17mAs 4.42-5mm slices and reconstructed to 
sagittal, axial, and coronal views. LSG and SPECT/CT images were analysed by a 
nuclear medicine physician (GG) and sentinel nodes were identified according to 
the definition: hotspots that appeared first, were on a direct drainage pathway 
from the tumour, or contained were more than 10% of the activity of the hottest 
node in the basin[34]. The position of the sentinel nodes were localised on the 
skin of the neck using a 57Cobalt point-source marker and were marked on the 
skin. Prior to surgery, imaging was reviewed jointly by GG and one of two 
surgeons (CS or MM) and the agreed location of sentinel nodes was recorded in a 
study proforma.  The remaining surgeon was kept blinded to the results and took 
the lead role during the operation. The skin markings were photographed and 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
removed before the patient was taken to theatre. The surgical approach was 
entirely based upon intraoperative fhSPECT imaging. 
2.2 Sentinel node imaging by fhSPECT 
 
Freehand SPECT imaging was undertaken using DeclipseSPECT SurgicEye 
(GmbH, Germany). Both sides of the neck were scanned until clear images of 
radiation hotspots were seen or at least 2000 counts were obtained. Sentinel 
nodes were identified by intensity of signal more than ten times the background 
radiation (signal to background ratio), automatically calculated by fhSPECT to 
show a hotspot on the augmented reality and 3-D images. Typical scanning time 
was 2-3 minutes. Acquired data (scans) were then used to navigate to the 
sentinel nodes. 
The protocol was designed for fhSPECT scans to be taken at two time points 
“Immediate fhSPECT” – DeclipseSPECT was transported to the nuclear 
medicine department and scans taken straight after radiotracer injection. 
“Intraoperative fhSPECT” - DeclipseSPECT was used in the operating room. 
Scans were taken immediately before the procedure and subsequently the 
system was used to navigate to the identified sentinel nodes during surgery. 
 
2.2.1 Immediate fhSPECT 
 
One-third of patients underwent immediate post injection fhSPECT scan 
performed prior to LSG and SPECT/CT. Freehand SPECT scan commenced five 
minutes after radiotracer injection. The fhSPECT scan was completed within five 
minutes but if unsuccessful, no further delay was permitted and the patient 
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proceeded with standard LSG and SPECT/CT protocol described above, to 
minimize disruption to the standard care pathway. 
 
 
2.2.2 Intraoperative fhSPECT 
 
In the operating theatre the lead (blinded) surgeon undertook fhSPECT scan  and 
the position of the identified sentinel nodes were marked on the neck. 
Intraopertive fhSPECT acquisition took no longer than 5 minutes in each case. 
Following the image acquisition, the surgeon used both augmented reality and 3-
D mode on the device to locate and excise the sentinel nodes. Results of  LSG and 
SPECT/CT were withheld until the sentinel node procedure was completed to 
the satisfaction of the lead surgeon. The only planned exception to this was in the 
case of no nodes being found by fhSPECT in which case the pre-operative 
imaging results were revealed at the beginning of the invasive procedure. 
 
2.3 Surgery 
 
Standard SNB retrieval was undertaken[2] based on fhSPECT results. All 
retrieved nodes were labelled according to neck level and gamma count.  
Once this process was completed and before the neck incisions were closed, the 
results of the lymphoscintigraphy and SPECT/CT were revealed by the non-
blinded surgeon. If there was discrepancy between the pre-operative imaging 
and the fhSPECT result (nodes not detected by fhSPECT) then the images were 
reviewed in full by both surgeons on a screen in theatre and a joint decision was 
made if further nodes required retrieval. All excised nodes were checked ex-vivo 
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to ensure the gamma count (averaged over 10 seconds) was more than three 
times the background radiation and more than 10% of the hottest node count. If 
these criteria were not met the node was considered a non-sentinel node. 
Sentinel nodes were processed by serial step sectioning according to published 
guidelines[1]. In brief, nodes were sectioned at 150 µm intervals with sections 
cut at each level. Sections were primarily stained by H&E, if no metastasis were 
detected immunohistochemical staining with AE1/3 pan-cytokeratin was 
performed. Metastasis were classified according to size (isolated tumour cells 
(<0.2mm), micrometastasis (0.2-2mm) and metastasis (>2mm))[35]. 
Patients were reviewed in clinic one week after surgery. If the biopsy proved 
positive for metastasis, a completion neck dissection was undertaken.  
3. Analysis  
 
Descriptive statistics were used with paired investigations used as the control.  
Primary outcome, SN detection by each technique (fhSPECT, SPECT/CT and LSG) 
was compared using one-way repeated measures analysis of variance (ANOVA) 
analysis.  
The second outcome was the detection of positive sentinel nodes. To consider 
fhSPECT a safe option it should to detect all the positive nodes (SN+) that had 
been found by other methods i.e. 100% concordance between LSG or SPECT/CT 
and fhSPECT for all SN+ cases.  
Univariate survival analysis models were built using Kaplan-Meier product-limit 
estimator for disease free survival (DFS). Table analysis on outcomes was 
performed using either chi-square or Fisher’ exact to test significance, depending 
upon the distribution of the variable in question.  
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4. Results  
 
Between November 2012 and November 2015 fifty patients were recruited to 
the study. Three patients undergoing SNB declined to enter the study and did not 
undergo navigation guided SNB by fhSPECT (Figure 1). 
Figure 1. Patient recruitment and outcomes. 
A total of 144 sentinel nodes were retrieved, an average of 2.88(+/-2.05) nodes 
per patient (range 1-8). The sentinel node biopsy was positive for metastasis in 
19 patients (38%), in three cases two positive sentinel nodes were identified 
therefore 22 positive nodes were excised. 
Patient and tumour characteristics are shown in table 1. 
 
 
Table.1 Characteristics of patient and tumour. 
 All patients 
(n=50) 
Positive Sentinel 
node biopsy  
(n=19) 
Effect of variable 
on sentinel node 
status  
Male (28/50) 56% (10/28) 36% p=0.7 
Female (22/50) 44% (9/22) 41% 
Age (years 
median, standard 
deviation) 
61.5   ±  
12.08 (range 24-
87) 
 p=0.61 
Positive SNB (19/50) 38%  
Negative SNB (31/50) 62% 
Tumour location 
Tongue (33/50) 66% (15/33)  45% p=0.3 
Floor of mouth  (8/50) 16% (2/8) 25% 
Lower alveolus (3/50) 6% (0/3) 0% 
Lower lip (2/50) 4% (1/2) 50% 
Retro-molar (1/50) 2% (1/1) 100% 
Buccal (2/50) 4% (0/2) 0% 
T stage (AJCC 7th Edition, 2010) 
T1 40 (80%) 12/40 (30%) p=0.02 
T2 10 (20%) 7/10 (70%) 
T stage (AJCC 8th Edition, 2016) 
T1 38 (76%) 9/38 (24%) p=0.001 
T2 9 (18%) 7/9 (78%) 
T3 3(6%) 3/3 (100%) 
N (sn) stage 
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4.1 Immediate fhSPECT scan 
 
Fifteen patients underwent fhSPECT scan. In three cases there was no clear 
drainage to the neck. In a further two cases there was drainage seen to the neck 
but the signal could not be isolated to a discrete area. The remaining ten cases 
had hot nodal areas detected that could be grouped into three patterns: 
i) No discernable drainage on immediate fhSPECT scan with clear 
drainage shown on subsequent scans (Fig 2A).  
ii) Clear drainage seen on immediate fhSPECT scan, but further drainage 
found on subsequent scans (Fig 2B).  
iii) Clear drainage seen on immediate scan with no additional hotspots 
found on subsequent scan (Fig 2C). 
Nine of the fifteen patients proved to have positive sentinel nodes by 
histopathological analysis (60%).  The positive sentinel node was located by 
immediate fhSPECT in only three of these cases, thus the sensitivity for detection 
of positive sentinel nodes was 33% and the false negative rate 40% (Table 2).  
Table 2: Cases that underwent immediate freehandSPECT (fhSPECT) scan following injection of 
radiotracer. FOM= Floor of mouth. * denotes sentinel node that was found to contain metastasis. 
N1 (16/19) 84%  
N2b (3/19) 16% 
Extracapsular spread/ Extranodal Extension 
Yes (3/19) 16%  
No (16/19) 84% 
Case  
Side of 
body 
Tumour 
location 
Dose of 
Nanocolloid 
(MBq) 
One or 
two day 
protocol Immediate fhSPECT result 
SNB 
Result 
1 Left Tongue 20 One Indeterminate drainage left neck  Positive 
2 Left FOM 20 One 
Left and right submental and right 
IIa Negative 
3 Right Tongue 20 One Right level IIa Negative 
4 Right Tongue 85 Two Right level IIa and Right level III Negative 
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Examples of cases are shown below (Figure 2) these demonstrate characteristic 
high signal and scatter which is found at the tumour site immediately post 
injection. 
 
Figure 2. Patterns of drainage found on immediate post injection fhSPECT scan compared to pre-
operative fhSPECT (2-24 hours post injection) 
 
4.2 Blinded fhSPECT compared to lymphoscintigraphy and SPECT/CT 
 
Of the 144 sentinel nodes excised 95 were identified by lymphoscintigraphy, 122 
by SPECT/CT and 125 by fhSPECT.  A sample case is shown in figure  3 
 
Figure 3. Sentinel node identification by SPECT/CT and lymphoscintigraphy versus fhSPECT. All 
modalities found three sentinel nodes. Neck markings by nuclear medicine (left) and surgeon (right) 
can be compared  
 
 
A one-way repeated measured analysis of variance (ANOVA) was conducted to 
evaluate the null hypothesis that there is no difference in the number of sentinel 
nodes localised by each modality. The results of the ANOVA indicate a significant 
effect, Wilks’ Lambda p<0.001. Follow up comparisons indicated that pair-wise 
5 Right Tongue 20 One Right level IIa Positive 
6 Left Lower lip 20 One Right and left Ib and left facial Negative 
7 Left Tongue 33 One Left level IIa * Positive 
8 Right Tongue 19 One Right level II/III* Positive 
9 Left Tongue 17 One No nodes found Positive 
10 Left Tongue 20 One Left Ib*  Left IIa Right IIa Positive 
11 Left FOM 20 One No nodes found Negative 
12 Right Lower lip 20 One Left and right facial, Left IIa Positive 
13 Midline FOM 54 Two R submental, right facial, Right III Negative 
14 Midline FOM 53 Two 
Indeterminate drainage right and 
left neck Positive 
15 Left Tongue 69 Two No nodes found Positive 
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difference between lymphoscintigraphy and both SPECT/CT and fhSPECT were 
significant (p=0.002) but comparison between SPECT/CT and fhSPECT were not 
(p=1.000).  
 
Lymphoscintigraphy failed to show any drainage in four patients. SPECT/CT 
showed no drainage in one patient and fhSPECT showed drainage in all patients. 
In two cases the surgical plan was changed after revealing the results of the 
SPECT/CT. In both cases further nodes were localised and excised. These nodes 
were negative for metastasis. 
There were no false negative results (neck recurrence after negative SNB) at 
minimum 24 months follow up.  However, all modalities missed positive nodes in 
at least one patient (Table 3). The false negative rate (FNR) was estimated for 
each imaging modality calculated as: true positive/(true positive + false 
negative). In this study a true positive result was encountered when an imaging 
modality identified sentinel nodes subsequently found to contain metastasis. A 
false negative result was recorded when an imaging modality failed to detect a 
sentinel node subsequently found to contain metastasis. The FNR was calculated 
on a per case rather than per node basis as the neck status correct biopsy result, 
neck status, only requires one positive node (i.e. a patient with one positive or 
more than one positive sentinel node will be treated the same, by completion 
neck dissection). The FNR for lymphoscintigraphy, SPECT/CT and fhSPECT was 
26.3%, 15.8% and 5.3% respectively. If we consider the hypothetical situation 
that all the positive nodes missed were left until clinically apparent the overall 
neck control rate (NCR) for each modality in this cohort (fifty patients, three 
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regional recurrences) would be 84%, 88% and 92% for LSG, SPECT/CT and 
fhSPECT 
 
 
 
Table 3. Number of positive nodes found by each modality 
 
 Missed positive cases  
(n=19) 
False negative 
rate 
Neck control rate 
 
LSG 5  
 
26.3%  84% 
SPECT/CT 3  
 
15.8% 88% 
fhSPECT 1  
 
5.3% 92% 
Total cohort (all 
modalities) 
0 0% 94% 
 
Freehand SPECT failed in to identify a positive node in one patient with a tongue 
tumour. The pre-operative fhSPECT scan identified a facial node and a level IIb 
node. Both pre-operative SPECT/CT and LSG found two hot areas in the left neck 
- level IIa and level III - of which the level IIa node was positive for metastasis.  
4.3 Survival 
 
Median follow up was 65 months (range 21-119 months). Five patients died 
from disease recurrence (three in the neck, two with distant metastasis), all were 
in the sentinel node positive group. Disease free survival for sentinel node 
positive versus sentinel node negative was significant (p<0.005) 
 5. Discussion  
 
Immediate fhSPECT was performed in 30% of the study group and provided new 
information in this field of investigation. The reason that not all patients could be 
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scanned immediately post-injection was due to clashing scheduling of both 
surgery and injection. Often, more than one SNB cases would be scheduled per 
day therefore the equipment was in use in theatre at the time that the second 
patient was undergoing injection.  
Nevertheless the experiences gained showed that immediate fhSPECT (< 10min 
post injection) is not reliable, with a false negative rate of 40%. This can be 
explained by the high level of signal at the injection site immediately after 
injection resulting in signal scatter and shine through effect masking signal 
tracking to the sentinel nodes.  
This study protocol did not allow delay of more than ten minutes between 
injection of the tracer and commencement of lymphoscintigraphy. This is due to 
historical concern about the risk of missing in-transit sentinel nodes. These are 
defined as nodes which the tracer completely passes through en-route to second 
echelon nodes, and can escape detection if only late images are taken.  In-transit 
nodes are recognised as rare occurrences and have been reported in melanoma 
but there are no reports of this situation occurring in oral cancer[1, 36, 37].  
In this study the performance of fhSPECT, particularly in the immediate post 
injection period was unknown and so the study was designed to alter the 
standard imaging pathway as little as possible. 
What has been shown clearly by these results is that lymphoscintigraphy 
performed poorly compared to both SPECT/CT and fhSPECT in the detection of 
SNs (p<0.005). There was no additional benefit to performing LSG (i.e. it did not 
identify nodes missed by other modalities) thus opening up the possibility that 
LSG could be omitted allowing serial fhSPECT scans to be taken in the immediate 
period following injection. SPECT/CT is normally performed after the LSG 
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protocol is finished, usually 90 minutes following injection. A future protocol for 
consideration is fhSPECT scan at ten-minute intervals post injection followed by  
SPECT/CT at 90 minutes. This would assess the real-time tracking capabilities of 
fhSPECT. The results of such an investigation would inform how applicable 
fhSPECT is to a purely intraopertive technique where it is imperative that the 
surgical flow is not interrupted for prolonged periods to allow drainage 
 
FreehandSPECT showed excellent sentinel node identification when used as an 
intraoperative tool, however it did miss a positive sentinel node in one case. In 
this patient two hotspots had been identified in the left neck by all three 
modalities, LSG and SPECT/CT localised to level IIa and III whereas fhSPECT 
showed a facial node and a level IIB node.  When the gamma probe was used 
independently of the navigation mode during the procedure, sentinel nodes were 
retrieved from level IIb and III. This suggests that there was a co-registration 
problem between the gamma probe and patient tracking device, leading to 
incorrect reconstruction of the gamma signal in three-dimensions.  
In this case a potential explanation is that the head position (and thus the patient 
tracking device) was moved during the data collection. The tracking device is 
attached to the forehead and will map accurately when the head is rotated in a 
neutral position however if any lateral flexion of the neck is introduced the 
relationship between the nodal hotspots and patient tracking device is changed 
and could explain why the nodes appeared to have been shifted superiorly in 
relation to the actual position. 
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6. Conclusion  
These data show that a surgeon who is naïve to the results of pre-operative 
sentinel node imaging can use freehand SPECT in the operating theatre to 
accurately locate sentinel lymph nodes. Freehand SPECT showed excellent 
sensitivity and a low false negative rate, but a higher detection of negative 
(possibly non-sentinel nodes). Data collected from immediate post injection 
fhSPECT is unreliable for SN node detection, suggesting that there is an as yet 
undefined optimum imaging window for this modality. It remains to be 
established if this imaging window coincides with a time frame that is 
compatible with intraoperative injection and sentinel node retrieval. 
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